|This article is outdated. (January 2014)|
|Systematic (IUPAC) name|
|Mol. mass||252.23 g/mol|
|(what is this?)|
Amdoxovir is a nucleoside reverse transcriptase inhibitor (NRTI) undergoing research for the treatment of HIV. It was discovered by Raymond F. Schinazi (Emory University) and C.K. Chu (University of Georgia). It is being developed by RFS Pharma. Currently, it is in Phase II clinical studies.
- Murphy RL, Kivel NM, Zala C, Ochoa C, Tharnish P, Mathew J, Pascual ML, Schinazi RF (2010). "Antiviral activity and tolerability of amdoxovir with zidovudine in a randomized double-blind placebo-controlled study in HIV-1-infected individuals". Antivir Ther 15 (2): 185–192. doi:10.3851/IMP1514. PMID 20386073.
|This antiinfective drug article is a stub. You can help Wikipedia by expanding it.|